Objective To assess the value of combined detection of tumor markers CEA, CA125, CA19-9 and CA50 in chemotherapy of non-small cell lung cancer (NSCLC).

• 摘要目的探讨联合检测肿瘤标记物CEA、CA125、CA19-9、CA50对于非小细胞肺癌化疗的意义。